ArticleDiscover oncology2025
A high-grade glioma metastasis to the thoracic spine: illustrative case and a brief review.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinal metastasis of high grade glioma (HGG) is a rare but serious clinical occurrence that can significantly impact patient prognosis and quality of life. Although the majority of HGG metastases are confined intracranially, extracranial spread, including spinal metastasis, has been increasingly recognized in recent years. Spinal involvement may occur through hematogenous spread, direct extension, or cerebrospinal fluid dissemination, with the most common sites being the vertebral bodies and epidural space. The clinical presentation of spinal metastasis often includes worsening back pain and neurological deficits which may require urgent surgery. Authors present a mini review of this important clinical condition with an insight of their own case and possibilities of treatment which is often limited due to the aggressive nature of HGG and the challenging management of spinal metastases. Surgical resection and oncologic therapy still remain the commonly established options to be employed, nevertheless outcomes remain poor and median survival times are generally short. Although rare, spinal metastasis of HGG needs more research in order to better understand the pathophysiology, optimal management strategies and long-term outcomes for affected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.